Aditxt, Inc. (NASDAQ:ADTX) Major Shareholder Sells $29,874.78 in Stock

Aditxt, Inc. (NASDAQ:ADTXGet Free Report) major shareholder Financial Lp Hrt sold 25,534 shares of the business’s stock in a transaction that occurred on Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total value of $29,874.78. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Aditxt Trading Down 4.5 %

ADTX traded down $0.05 during trading hours on Thursday, reaching $1.06. The company’s stock had a trading volume of 1,923,192 shares, compared to its average volume of 519,638. The business’s 50-day moving average is $0.82 and its 200-day moving average is $1.56. Aditxt, Inc. has a fifty-two week low of $1.01 and a fifty-two week high of $520.00.

Aditxt (NASDAQ:ADTXGet Free Report) last posted its earnings results on Monday, August 19th. The company reported ($4.19) EPS for the quarter. The company had revenue of $0.04 million during the quarter.

About Aditxt

(Get Free Report)

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.

Featured Articles

Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.